Skip to main content
. 2021 Jun 8;11:641833. doi: 10.3389/fonc.2021.641833

Figure 2.

Figure 2

DUXAP9 was identified as an oncogenic factor and predicted poor prognosis in localized ccRCC patients in the TCGA database. (A) DUXAP9 expression in 445 localized ccRCC tissues and 72 normal tissues in the TCGA database. (B–D) DUXAP9 expression increased with increasing T classification, stage, and Furman grade. (E, F) Kaplan–Meier analyses confirmed that high DUXAP9 expression (n=103) in localized ccRCC tissues was significantly associated with poor OS and PFS, compared with low expression (n=342). ccRCC, clear cell renal cell carcinoma; TCGA, The Cancer Genome Atlas; OS, overall survival; PFS, progression-free survival.